Skip to main content
COCH
NASDAQ Industrial Applications And Services

Controlling Shareholder Glen Taylor Invests $7.5M in Recent Dilutive Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.57
Mkt Cap
$46.129M
52W Low
$0.363
52W High
$1.91
52W Position info
57% above low
Off High info
70% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

COCH sits 57% above its 52-week low of $0.363.

Summary

Controlling shareholder Glen A. Taylor purchased $7.5 million worth of common stock and warrants in Envoy Medical's recent public offering, demonstrating significant commitment and providing crucial capital.


Key Events · Ownership and Investor Activity · COCH

  • Controlling Shareholder Investment

    Glen A. Taylor purchased $7.5 million in common stock and warrants in the company's recent public offering on February 12, 2026.

  • Significant Capital Infusion

    This investment represents a substantial portion of the company's market capitalization and provides critical funding following a highly dilutive $30 million offering.

  • Increased Ownership Stake

    Following the purchase, Taylor beneficially owns 68,909,614 shares, representing 84.8% of the Class A Common Stock outstanding (including exercisable warrants).


Analysis · COCH · Industrial Applications And Services

This Schedule 13D/A filing reveals that Glen A. Taylor, a controlling shareholder of Envoy Medical, invested $7.5 million in the company's recent public offering on February 12, 2026. This substantial investment, representing a significant portion of the company's market capitalization, provided critical capital for the company, which recently finalized a highly dilutive $30 million offering at a deep discount. Taylor's participation, acquiring 18.75 million shares and accompanying warrants, signals strong conviction in the company's future despite the dilutive nature of the capital raise. This insider commitment is a significant positive development, especially given the company's recent need for financing to fund its FDA pivotal clinical study.

How filings like this one have moved

In the 30 days to Sep 12, 2026, 42% of the 479 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, COCH was trading at $0.57 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $46.1M. The 52-week trading range was $0.36 to $1.91. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

COCH - Latest Insights

COCH
Aug 31, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $0.7103 info
Change: -$0.0097 (-1%) info
Market Cap: $57.287M info
COCH
Aug 19, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $0.7103 info
Change: -$0.0297 (-4%) info
Market Cap: $57.287M info
COCH
Aug 10, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.705
Real-time Price: $0.7103 info
Change: +$0.0053 (+0.75%) info
Market Cap: $57.287M info
COCH
Aug 10, 2026, 8:31 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.6932
Real-time Price: $0.7103 info
Change: +$0.0171 (+2%) info
Market Cap: $57.287M info
COCH
Jul 21, 2026, 9:17 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.706
Real-time Price: $0.7103 info
Change: +$0.0043 (+0.61%) info
Market Cap: $57.287M info